Baseline variables | Univariate | Multivariate | ||
---|---|---|---|---|
Crude HR (95%CI) | p-value | Adjusted HRa (95%CI) | p-value | |
Normoalbuminuria | Reference | 1 | Reference | 1 |
Microalbuminuria | 1.82 (1.15, 2.89) | 0.011 | 1.4 (0.8, 2.44) | 0.235 |
Macroalbuminuria | 4.09 (2.12, 7.88) | < 0.001 | 3.13 (1.4, 6.96) | 0.005 |
Age (years) | 1.04 (1.02, 1.05) | < 0.001 | 1.02 (1, 1.05) | 0.084 |
Male (%) | 1.55 (1.02, 2.36) | 0.04 | 1.26 (0.74, 2.15) | 0.397 |
BMI (kg/m2) | 1.02 (0.96, 1.08) | 0.498 | Â | Â |
Systolic BP (mmHg) | 1.01 (0.99, 1.02) | 0.266 | Â | Â |
Diastolic BP (mmHg) | 1 (0.98, 1.02) | 0.867 | Â | Â |
History of Hypertension | 3.26 (2.14, 4.95) | < 0.001 | 2.6 (1.35, 5) | 0.004 |
History of Type2 DM | 3.18 (1.95, 5.19) | < 0.001 | 1.64 (0.48, 5.66) | 0.43 |
History of Dyslipidemia | 1.6 (0.85, 3.02) | 0.143 | Â | Â |
History of smoking (%) | 1.33 (0.82, 2.16) | 0.249 | Â | Â |
Serum creatinine (mg/dL) | 3.85 (1.53, 9.68) | 0.004 | Â | Â |
eGFR (ml/min/1.73m2) | 0.98 (0.97, 0.99) | < 0.001 | 0.99 (0.98, 1.01) | 0.365 |
Aspirin (use) | 6.73 (4.33, 10.49) | < 0.001 | 5.28 (2.75, 10.14) | < 0.001 |
ACEI/ARBs (use) | 2.86 (1.79, 4.57) | < 0.001 | 0.64 (0.32, 1.27) | 0.204 |
Insulin (use) | 5.67 (2.84, 11.31) | < 0.001 | 1.19 (0.42, 3.4) | 0.738 |
Metformin (use) | 2.41 (1.36, 4.28) | 0.003 | 0.29 (0.09, 0.94) | 0.038 |